At the end of the day the good guys always win. I
Post# of 148187
“In contrast, Gilead’s DoJ’s investigation was related to kick-backs to FDA employees and resulted in a $97 million fine. Then there was the $2.8 billion settlement with Purdue Pharma over misleading marketing of Suboxone opioid addiction therapy. The DoJ is also going after Teva Pharmaceuticals for their conspiracy to subsidize Medicare co-pays for Copaxone which is a multiple sclerosis therapy. The DoJ targets bad actors with Revenues not developmental stage pharma companies. The DoJ follows the money”